| __timestamp | Ascendis Pharma A/S | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 13983000 | 20272000000 |
| Thursday, January 1, 2015 | 8118000 | 19652000000 |
| Friday, January 1, 2016 | 4606000 | 21903000000 |
| Sunday, January 1, 2017 | 1530000 | 22385000000 |
| Monday, January 1, 2018 | 10581000 | 18854000000 |
| Tuesday, January 1, 2019 | 13375000 | 16887000000 |
| Wednesday, January 1, 2020 | 6953000 | 16658000000 |
| Friday, January 1, 2021 | 7778000 | 15878000000 |
| Saturday, January 1, 2022 | 51174000 | 14925000000 |
| Sunday, January 1, 2023 | 266718000 | 15846000000 |
| Monday, January 1, 2024 | 363641000 | 16544000000 |
In pursuit of knowledge
In the competitive landscape of pharmaceuticals, Teva Pharmaceutical Industries Limited and Ascendis Pharma A/S present a fascinating revenue trajectory from 2014 to 2023. Teva, a stalwart in the industry, consistently reported revenues exceeding $15 billion annually, peaking in 2017. However, a gradual decline of approximately 30% was observed by 2022, reflecting market challenges and strategic shifts.
Conversely, Ascendis Pharma, a relatively newer player, showcased a remarkable growth story. Starting with modest revenues in 2014, Ascendis experienced an exponential surge, culminating in a staggering 5,000% increase by 2023. This growth underscores Ascendis's innovative approach and successful market penetration.
This revenue showdown highlights the dynamic nature of the pharmaceutical sector, where established giants face challenges, and emerging companies seize opportunities to redefine industry standards.
Comparing Revenue Performance: Eli Lilly and Company or Ascendis Pharma A/S?
Breaking Down Revenue Trends: Teva Pharmaceutical Industries Limited vs Sarepta Therapeutics, Inc.
R&D Insights: How Teva Pharmaceutical Industries Limited and Ascendis Pharma A/S Allocate Funds
Breaking Down Revenue Trends: Teva Pharmaceutical Industries Limited vs TG Therapeutics, Inc.
Revenue Showdown: Teva Pharmaceutical Industries Limited vs Merus N.V.
Breaking Down Revenue Trends: Teva Pharmaceutical Industries Limited vs Mesoblast Limited
Revenue Insights: Teva Pharmaceutical Industries Limited and Galapagos NV Performance Compared
Biogen Inc. or Ascendis Pharma A/S: Who Leads in Yearly Revenue?
Ascendis Pharma A/S or MorphoSys AG: Who Leads in Yearly Revenue?
Ascendis Pharma A/S and Merus N.V.: A Comprehensive Revenue Analysis
Ascendis Pharma A/S and Supernus Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Ascendis Pharma A/S or Dynavax Technologies Corporation: Who Leads in Yearly Revenue?